Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 4/20 | 0.39 |
| ▸ | TSHR | P16473 | 4/20 | 0.37 |
| ▸ | HPGD | P15428 | 3/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | CASP1 | P29466 | 2/20 | 0.37 |
| ▸ | CASP7 | P55210 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.36 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.36 |
| ▸ | GPR3 | P46089 | 1/20 | 0.35 |
| ▸ | AHR | P35869 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | MAOA | P21397 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29660297 | 0.83 | CYP1A2 (0.53) | CYP1A2TSHRHPGDHSD17B10L3MBTL1 | |
| SCHEMBL357443 | 0.83 | CYP1A2 (0.53) | CYP1A2TSHRHPGDHSD17B10L3MBTL1 | |
| SCHEMBL28539881 | 0.80 | CYP1A2 (0.50) | CYP1A2TSHRHPGDHSD17B10L3MBTL1 | |
| Ammonia Solution, Strong SCHEMBL2263911 | 0.80 | CYP1A2 (0.50) | CYP1A2TSHRHPGDHSD17B10L3MBTL1 | |
| Hydrazine SCHEMBL394386 | 0.77 | CYP1A2 (0.47) | CYP1A2TSHRHPGDHSD17B10L3MBTL1 | |
| SCHEMBL167933 | 0.76 | CYP1A2 (0.53) | CYP1A2TSHRHPGDHSD17B10L3MBTL1 | |
| SCHEMBL11038752 | 0.74 | CYP1A2 (0.39) | CYP1A2TSHRHPGDHSD17B10L3MBTL1 | |
| SCHEMBL377040 | 0.73 | CYP1A2 (0.56) | CYP1A2TSHRHPGDHSD17B10L3MBTL1 | |
| SCHEMBL29379467 | 0.73 | CYP1A2 (0.56) | CYP1A2TSHRHPGDHSD17B10L3MBTL1 | |
| Anthraquinone SCHEMBL1376042 | 0.73 | ALDH1A1 (0.41) | CYP1A2TSHRHPGDHSD17B10CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240125678-A1 | COMPOUND, CELLULAR VESICLE STAIN, AND METHOD FOR FLUORESCENT STAINING OF CELLULAR VESICLES | NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM (JP) | 2024-04-18 | — | — | US | disclosed |
| WO-2024053316-A1 | COMPOUND, EXTRACELLULAR VESICLE STAINING AGENT, AND FLUORESCENT STAINING METHOD FOR EXTRACELLULAR VESICLES | 国立大学法人東海国立大学機構 | 2024-03-14 | — | — | WO | disclosed |
| EP-4286388-A1 | COMPOUND, CELLULAR VESICLE STAIN, AND METHOD FOR FLUORESCENT STAINING OF CELLULAR VESICLES | National University Corporation Tokai National Higher Education and Research System (JP) | 2023-12-06 | — | — | EP | disclosed |
| CN-116745272-A | Compound, cell vesicle staining agent, and method for fluorescent staining of cell vesicles | 国立大学法人东海国立大学机构 | 2023-09-12 | — | — | CN | disclosed |
| US-5629406-A | AMINO ACID DERIVATIVES | SANKYO COMPANY, LIMITED (JP) | 1997-05-13 | — | — | US | disclosed |
| EP-0587311-A1 | Peptides capable of inhibiting the activity of HIV protease, their preparation and their therapeutic use | SANKYO COMPANY LIMITED (JP) | 1994-03-16 | — | — | EP | disclosed |
| US-4701565-A | REACTING ALCOHOL WITH ORGANIC SULFONYL HALIDE TO FORM SULFONATE, REACTING SULFONATE WITH A PHENOL | FUJI PHOTO FILM CO., LTD. (JP) | 1987-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240125678-A1 | COMPOUND, CELLULAR VESICLE STAIN, AND METHOD FOR FLUORESCENT STAINING OF CELLULAR VESICLES | EXOSC4, EXOSC5, EXOSC9 | CYP1A2 3942/4885TSHR 3500/4885HPGD 4216/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.